A study to evaluate the immune response and safety of a vaccine against influenza in adults 18-64 years of age

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: d8da74b09cbf7f24a4ba869e2bdd41945488ac71
First added on: Nov 01, 2026